Laryngoport

Company Overview

Snapshot

Founded in November 2010 by Moshe Hain and Yonatan Lahav, Laryngoport operates with 1–10 employees. The company has secured $1 million in total capital across one funding round from three investors. In November 2010, Laryngoport launched an innovative technological tool designed to provide optimal surgical exposure for laryngeal microsurgery.

Business overview

Laryngoport develops a flexible endoscopic platform specifically engineered for laryngeal microsurgical procedures. This technology aims to enhance visualization and surgical access, leading to greater precision, reduced tissue damage, and improved efficiency compared to traditional methods. The company operates within the Health Tech & Life Sciences sector, focusing on Medical Devices and Medical Treatment & Therapeutics, serving the Healthcare industry and providers.

Company Intelligence Q&A

What is Laryngoport's primary focus?

Laryngoport's primary focus is on developing a flexible endoscopic platform for laryngeal microsurgical procedures, aiming to improve surgical precision and efficiency.

When was Laryngoport founded?

Laryngoport was founded in November 2010.

Who are the founders of Laryngoport?

Laryngoport was founded by Moshe Hain and Yonatan Lahav.

What is the status of Laryngoport?

Laryngoport is currently non-active, having ceased operations in September 2024.

What was a key technological development by Laryngoport?

In November 2010, Laryngoport introduced an innovative technological tool designed to provide optimal surgical exposure for endoscopy and surgical procedures.